Skip to Content
Merck
CN

H6508

Sigma-Aldrich

Heparin−Agarose

Type I, saline suspension

Synonym(s):

Heparin beads, Heparin resin

Sign Into View Organizational & Contract Pricing

Select a Size

About This Item

MDL number:
MFCD00163876
UNSPSC Code:
23151817
NACRES:
NA.56

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

biological source

heparin from Porcine intestinal mucosa

Quality Level

200

type

Type I

form

saline suspension

extent of labeling

400-1500 μg per mL packed gel (activity approx. 140 USP units per mg)

technique(s)

affinity chromatography: suitable

matrix

cross-linked 4% beaded agarose

matrix activation

cyanogen bromide

matrix attachment

amino

matrix spacer

1 atom

suitability

suitable for chromatography

storage temp.

2-8°C

Looking for similar products? Visit Product Comparison Guide

Application

Heparin-agarose is developed from porcine intestinal mucosa and is used in affinity chromatography. Heparin-agarose has been used in studies to provide information on human monocytic ehrlichiosis, tumor necrosis and the effects of coagulation from Vipera snake venom.

Physical form

Suspension in 0.5 M NaCl containing preservative

Storage Class Code

10 - Combustible liquids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000477200
0000477200
0000368331
0000368331
0000366768

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Analysis of Adeno-Associated Virus and HPV Interaction.
Hermonat, P.L., et al.
Methods in Molecular Medicine, 119, 397-409 (2006)
G Glaser et al.
Archives of virology, 143(10), 1967-1983 (1998-12-18)
The immediate early BRLF1 and BZLF1 promoters of Epstein-Barr virus are crucial for triggering the replicative cycle of the virus. To better understand the cell type dependence of the lytic cycle we conducted an analysis of the BRLF1-promoter in the
Alejandra Loyola et al.
Methods (San Diego, Calif.), 31(1), 96-103 (2003-08-02)
It is becoming clear that the structure of cellular chromatin is dynamic and capable of undergoing rapid changes to respond to the metabolic requirements of the cell. These changes have a direct impact on gene expression and, therefore, the chromatin
91. Universal purification of AAV serotypes 1?5 modified to contain a heparin binding epitope.
Faust, S.M., et al.
Molecular Therapy, 9, S36-S36 (2004)
M E Silvestri et al.
Scandinavian journal of immunology, 53(3), 282-289 (2001-03-17)
An investigation was performed into the heparin-binding properties of a synthetic peptide deduced from the sequence of human cytomegalovirus glycoprotein B. The peptide, T7-13:3, amino acids 69-78, which was previously shown to contain a neutralization epitope was able to bind
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service